PD-217014

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePD-217014
Drug Alias NamePD-217PD-217014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel modulators
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsPainIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaNetherlands +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsPainIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksWikipedia